{"created":"2021-03-01T07:11:27.548248+00:00","id":32732,"links":{},"metadata":{"_buckets":{"deposit":"ebb3a903-d121-47c3-b4a6-480eb528b345"},"_deposit":{"id":"32732","owners":[],"pid":{"revision_id":0,"type":"depid","value":"32732"},"status":"published"},"_oai":{"id":"oai:tsukuba.repo.nii.ac.jp:00032732","sets":["2770:2773","3:62:5297:1814"]},"item_5_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2015-02","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"3","bibliographicPageEnd":"448","bibliographicPageStart":"439","bibliographicVolumeNumber":"23","bibliographic_titles":[{"bibliographic_title":"Bioorganic & medicinal chemistry"}]}]},"item_5_creator_3":{"attribute_name":"著者別名","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"長瀬, 博"}],"nameIdentifiers":[{}]}]},"item_5_description_4":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"We transformed naltrexone (5) with the morphinan skeleton into mesembrane (4) belonging to the Sceletium alkaloids via key intermediate 6, characterized by a cis-fused hydroindole skeleton with a suspended phenyl ring fixed by an epoxy bridge. We then investigated the binding affinities of 4 and the key intermediate 6 derivatives to the opioid receptors. Among the tested compounds, 15′, with a cis-fused hydroindole core, bound to the three opioid receptor types with strong to moderate affinities. The observed differences of binding affinities among the tested compounds were reasonably explained by the conformational analyses of the compounds. The structure–activity relationship (SAR) of the tested compounds like 15′ with the hydroindole structure was completely different from the reported SAR of morphinan derivatives with the hydroisoquinoline skeleton. Compound 15′ with a structure that differs from the morphinans represents a useful fundamental skeleton with a novel chemotype that may contribute to the development of new opioid ligands.","subitem_description_type":"Abstract"}]},"item_5_publisher_27":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"Elsevier"}]},"item_5_relation_10":{"attribute_name":"PubMed番号","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"25573119","subitem_relation_type_select":"PMID"}}]},"item_5_relation_11":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"10.1016/j.bmc.2014.12.032","subitem_relation_type_select":"DOI"}}]},"item_5_rights_12":{"attribute_name":"権利","attribute_value_mlt":[{"subitem_rights":"© 2014 Elsevier Ltd."},{"subitem_rights":"NOTICE: this is the author’s version of a work that was accepted for publication in Bioorganic & medicinal chemistry. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Bioorganic & medicinal chemistry, 23(3),2015 doi:10.1016/j.bmc.2014.12.032"}]},"item_5_select_15":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_select_item":"author"}]},"item_5_source_id_7":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0968-0896","subitem_source_identifier_type":"ISSN"}]},"item_5_source_id_9":{"attribute_name":"書誌レコードID","attribute_value_mlt":[{"subitem_source_identifier":"AA10938083","subitem_source_identifier_type":"NCID"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Konoura, Kazuya"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Fujii, Hideaki"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Imaide, Satomi"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Gouda, Hiroaki"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Hirayama, Shigeto"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Hirono, Shuichi"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Nagase, Hiroshi"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2015-03-05"}],"displaytype":"detail","filename":"BMC_23-3.pdf","filesize":[{"value":"391.7 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"BMC_23-3","url":"https://tsukuba.repo.nii.ac.jp/record/32732/files/BMC_23-3.pdf"},"version_id":"4ade7b23-e59e-4aff-9776-aaebc1be633e"},{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2015-03-05"}],"displaytype":"detail","filename":"BMC_23-3_Suppl.pdf","filesize":[{"value":"134.8 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"BMC_23-3_Suppl","url":"https://tsukuba.repo.nii.ac.jp/record/32732/files/BMC_23-3_Suppl.pdf"},"version_id":"9190dcfc-2b8a-4aca-b472-5e527ed2dbf2"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Transformation of naltrexone into mesembrane and investigation of the binding properties of its intermediate derivatives to opioid receptors","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Transformation of naltrexone into mesembrane and investigation of the binding properties of its intermediate derivatives to opioid receptors"}]},"item_type_id":"5","owner":"1","path":["2773","1814"],"pubdate":{"attribute_name":"公開日","attribute_value":"2015-03-05"},"publish_date":"2015-03-05","publish_status":"0","recid":"32732","relation_version_is_last":true,"title":["Transformation of naltrexone into mesembrane and investigation of the binding properties of its intermediate derivatives to opioid receptors"],"weko_creator_id":"1","weko_shared_id":5},"updated":"2022-04-27T09:00:55.592969+00:00"}